Osvaldo M. Basmadjian
Cordoba, X, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Working memory deficits and altered prefrontal-hippocampal activation in p35 knockout mice with ADHD-like phenotypes: influence of sex and acute monoaminergic treatments.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: June 01, 2026
Repeated Amphetamine Exposure Blunted Angiotensin II-Induced Responses Mediated by AT1 Receptors.
Journal: Discovery medicine
Published: January 24, 2025
Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications.
Journal: The European journal of neuroscience
Published: August 29, 2023
IGF-1 gene therapy prevents spatial memory deficits and modulates dopaminergic neurodegeneration and inflammation in a parkinsonism model.
Journal: Brain, behavior, and immunity
Published: August 22, 2023
Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor.
Journal: Behavioural brain research
Published: October 09, 2021
Amphetamine Induces Oxidative Stress, Glial Activation and Transient Angiogenesis in Prefrontal Cortex via AT1-R.
Journal: Frontiers in pharmacology
Published: December 30, 2020
Brain angiotensin II in dopaminergic imbalance-derived pathologies: neuroinflammation and vascular responses.
Journal: Neural regeneration research
Published: September 28, 2020
AT1 -R is involved in the development of long-lasting, region-dependent and oxidative stress-independent astrocyte morphological alterations induced by Ketamine.
Journal: The European journal of neuroscience
Published: January 15, 2020
Sex frailty differences in ageing mice: Neuropathologies and therapeutic projections.
Journal: The European journal of neuroscience
Published: July 30, 2019
Angiotensin II modulates amphetamine-induced glial and brain vascular responses, and attention deficit via angiotensin type 1 receptor: Evidence from brain regional sensitivity to amphetamine.
Journal: The European journal of neuroscience
Published: April 22, 2019
Novel adenoviral IGF-1 administration modulates the association between depressive symptoms and aging: Does gender matter?
Journal: Behavioural brain research
Published: March 01, 2019
Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT1 receptor activation.
Journal: The European journal of neuroscience
Published: February 02, 2017
Last Updated: 09/26/2026